Vanguard Capital Management
LSTA icon

Vanguard Capital Management’s Lisata Therapeutics LSTA Stock Holding History

Vanguard Capital Management’s Portfolio LSTA Stock Details LSTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$948K Buy
278,837
+7,022
+3% +$25K ﹤0.01% 3603
2026
Q1 		$1.36M Buy
+271,815
New +$1.12M ﹤0.01% 3481

Other funds holding LSTA

YCM
Yakira Capital Management Westport, Connecticut $351M AUM 21.8% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.57B AUM 67.14% 1-Year Est. Return
DAM
Deltec Asset Management New York $677M AUM 31.67% 1-Year Est. Return
RC
Rangeley Capital New Canaan, Connecticut $109M AUM 97.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
GS
GTS Securities Miami, Florida $4.75B AUM 41.97% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management's LSTA Position: Q2 2026 in Review

Vanguard Capital Management increased its Lisata Therapeutics (LSTA) stake by 2.6% in Q2 2026, buying an estimated $25K and bringing the position to 278,837 shares worth $948K. The position accounts for ﹤0.01% of the portfolio, ranked #3603.

Vanguard Capital Management first reported a position in LSTA in Q1 2026 and has held it in 2 quarters since. The position peaked at $1.36M in Q1 2026. 30 funds tracked by Wall St. Rank hold LSTA as of Q2 2026.

  • Vanguard Capital Management held 278,837 shares of Lisata Therapeutics worth $948K as of Q2 2026.
  • Vanguard Capital Management bought 7,022 Lisata Therapeutics shares in Q2 2026, an estimated $25K.
  • Lisata Therapeutics made up ﹤0.01% of Vanguard Capital Management's portfolio in Q2 2026, its #3603 holding.
  • Vanguard Capital Management first reported a position in Lisata Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Capital Management's Lisata Therapeutics position peaked at $1.36M in Q1 2026.
  • 30 funds tracked by Wall St. Rank held Lisata Therapeutics as of Q2 2026.

Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.